Abstract
Curcuma longa has been mentioned in the Indian system of medicine for the management of a wide range of diseases. C. longa and its metabolites like curcumin, ar-turmerone, methylcurcumin, demethoxy-curcumin, and bisdemethoxycurcumin have also been reported to be beneficial in various types of cancer. Curcumin elicits anticancer properties chiefly by triggering apoptotic pathways in cancer cells. The properties are facilitated through diverse signaling pathways viz. pathways mediated by NF-kB, WNT/β-catenin pathway COX-2, LOX, STAT3, prostaglandin E2, phosphorylase kinase, VEGF, AKT, AP1, STAT3, PI3K, Akt, mTOR, ERK5, AP-1, TGF-b, PPARc, EBPa, NLRP3 inflammasome, p38MAPK, Nrf2, Notch-1, AMPK, TLR-4, etc. The present article highlights curcumin biosynthesis, phytochemistry and diverse molecular pathways involved in regulating several types of secondary messengers to exhibit anticancer activity in almost all the forms of cancer.
Keywords: Curcumin, cancer, phytochemistry, molecular pathways, apoptosis, curcuma longa.
Graphical Abstract
Mini-Reviews in Medicinal Chemistry
Title:Curcumin: An Insight into Molecular Pathways Involved in Anticancer Activity
Volume: 21 Issue: 17
Author(s): Priyanka Joshi, Sushil Joshi, Deepak Semwal, Akansha Bisht, Sarvesh Paliwal, Jaya Dwivedi and Swapnil Sharma*
Affiliation:
- Department of Pharmacy, Banasthali Vidyapith, Banasthali, Rajasthan,India
Keywords: Curcumin, cancer, phytochemistry, molecular pathways, apoptosis, curcuma longa.
Abstract: Curcuma longa has been mentioned in the Indian system of medicine for the management of a wide range of diseases. C. longa and its metabolites like curcumin, ar-turmerone, methylcurcumin, demethoxy-curcumin, and bisdemethoxycurcumin have also been reported to be beneficial in various types of cancer. Curcumin elicits anticancer properties chiefly by triggering apoptotic pathways in cancer cells. The properties are facilitated through diverse signaling pathways viz. pathways mediated by NF-kB, WNT/β-catenin pathway COX-2, LOX, STAT3, prostaglandin E2, phosphorylase kinase, VEGF, AKT, AP1, STAT3, PI3K, Akt, mTOR, ERK5, AP-1, TGF-b, PPARc, EBPa, NLRP3 inflammasome, p38MAPK, Nrf2, Notch-1, AMPK, TLR-4, etc. The present article highlights curcumin biosynthesis, phytochemistry and diverse molecular pathways involved in regulating several types of secondary messengers to exhibit anticancer activity in almost all the forms of cancer.
Export Options
About this article
Cite this article as:
Joshi Priyanka , Joshi Sushil , Semwal Deepak , Bisht Akansha , Paliwal Sarvesh , Dwivedi Jaya and Sharma Swapnil *, Curcumin: An Insight into Molecular Pathways Involved in Anticancer Activity, Mini-Reviews in Medicinal Chemistry 2021; 21 (17) . https://dx.doi.org/10.2174/1389557521666210122153823
DOI https://dx.doi.org/10.2174/1389557521666210122153823 |
Print ISSN 1389-5575 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5607 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Androgen Receptor: Past, Present and Future
Current Drug Targets Advances and Implications in Nanotechnology for Lung Cancer Management
Current Drug Metabolism Synthesis of 2-Thiohydantoins as Somatostatin Subtype 4 Receptor Ligands
Letters in Drug Design & Discovery Potential Role of Natural Compounds as Anti-Angiogenic Agents in Cancer
Current Vascular Pharmacology Presence of HIV-1 DNA in Spermatozoa from HIV-Positive Patients: Changes in the Semen Parameters
Current HIV Research Structural Neuroimaging Findings in Major Depressive Disorder Throughout Aging: A Critical Systematic Review of Prospective Studies
CNS & Neurological Disorders - Drug Targets Differentiation of iNKT Cells from Embryonic Stem Cells
Current Immunology Reviews (Discontinued) Nutrition in Allogeneic Stem Cell Transplantion - Clinical Guidelines and Immunobiological Aspects
Current Pharmaceutical Biotechnology Lipid Membrane; A Novel Target for Viral and Bacterial Pathogens
Current Drug Targets Cell-Permeable Peptide Inhibitor of c-Jun NH2-Terminal Kinase for the Treatment of Diabetes
Current Bioactive Compounds The Role of Quercetin, Flavonols and Flavones in Modulating Inflammatory Cell Function
Inflammation & Allergy - Drug Targets (Discontinued) A Therapeutic Potential of Animal β-hairpin Antimicrobial Peptides
Current Medicinal Chemistry Patent Selections
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) Myocardial Ischemia and Reperfusion Injury: Studies Using Transgenic and Knockout Mice
Current Genomics Role of Fc Receptors as a Therapeutic Target
Inflammation & Allergy - Drug Targets (Discontinued) Post-Stroke Immunodepression and Infection: An Emerging Concept
Infectious Disorders - Drug Targets Chromogranin A and the Endothelial Barrier Function
Current Medicinal Chemistry Targeting the Toll of Drug Abuse: The Translational Potential of Toll-Like Receptor 4
CNS & Neurological Disorders - Drug Targets The Role of miRNAs in Cartilage Homeostasis
Current Genomics HIV/AIDS Curable Study: New Forms of Therapeutic Trinity
Recent Patents on Anti-Infective Drug Discovery